Moreover, the delivery of siRNA against ciRS-122 via exosomes was shown to reverse oxaliplatin resistance in cell culture and tumor-bearing mouse models by inhibiting the ciRS-122/miR-122/PKM2 ceRNA network, thus inhibiting glycolysis and drug resistance[70]. This evidence concerns the gene PKM and neoplasm.